Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Cleveland Clinic Heart & Vascular Institute
  • 4.3 (38)
  • HEALTH & FITNESS
  • UPDATED BIWEEKLY
Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.

  1. Talking Tall Rounds®: TAVR vs SAVR - Small Annulus Considerations

    6 DAYS AGO

    Talking Tall Rounds®: TAVR vs SAVR - Small Annulus Considerations

    Amar Krishnaswamy, MD, provides the TAVR perspective on SAVR in patients with small annulus, including outcomes of TAVR vs SAVR. Learn more about Tall Rounds online. http://2207941.mediaspace.kaltura.com/category/Tall+Rounds/75663251

    5 min
  2. Which Heart Health Diet Should you Recommend for Your Patient?

    JAN 2

    Which Heart Health Diet Should you Recommend for Your Patient?

    Diets for heart health are not one size fits all. Julia Zumpano, RD. discusses several different heart health diets and how to help your patient determine the best option for them. Learn more about Preventive Cardiology & Rehabilitationhttps://my.clevelandclinic.org/departments/heart/depts/preventive-cardiology-rehabilitationLooking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

    16 min
  3. Aortic Valve Imaging & Clinical Considerations

    12/26/2024

    Aortic Valve Imaging & Clinical Considerations

    Leonardo Rodriguez, MD, discusses patient prosthesis mismatch, imaging and clinical considerations for the aortic valve. Learn more about Tall Rounds online. http://2207941.mediaspace.kaltura.com/category/Tall+Rounds/75663251

    11 min
  4. Long-term Risk of Heart Attack, Stroke and Death Doubles with History of COVID-19 Infection

    12/19/2024

    Long-term Risk of Heart Attack, Stroke and Death Doubles with History of COVID-19 Infection

    The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis. Stanley Hazen, MD, PhD summarizes the findings of this Cleveland Clinic led trial and implications for practice and future research. Learn more about C5 Research at Cleveland Clinichttps://my.clevelandclinic.org/research/c5researchLooking to refer a patient? Please reach out to our Physician Refer...

    14 min
  5. Talking Tall Rounds®: Cardiac Sarcomas

    12/12/2024

    Talking Tall Rounds®: Cardiac Sarcomas

    Eric Roselli, MD, provides an overview, a complex cardiac sarcoma case is presented by Holliann Willekes, MD, followed by an update on imaging modalities from Patrick Collier, MD, PhD, and a perspective on pathology from Marc Halushka, MD, PhD. Learn more about Tall Rounds online. http://2207941.mediaspace.kaltura.com/category/Tall+Rounds/75663251

    19 min
  6. Diversity in Medicine

    12/05/2024

    Diversity in Medicine

    Lee Kirksey, MD, moderates a panel discussion on diversity in medicine with Miriam Jacob, MD, Milind Desai, MD, James Carter, MD, and Quinn Capers, MD, Visiting Professor from Howard University.

    5 min
  7. Oral Anticoagulation Compared to Left Atrial Appendage Closure Following Catheter Ablation: Results From the OPTION Trial

    11/27/2024

    Oral Anticoagulation Compared to Left Atrial Appendage Closure Following Catheter Ablation: Results From the OPTION Trial

    A Cleveland Clinic-led trial found that a minimally-invasive procedure – left atrial appendage closure (LAAC) – resulted in significantly less bleeding in patients undergoing a catheter ablation to treat atrial fibrillation, compared to oral anticoagulation, while preserving low rates of stroke, blood clots and death. The OPTION Trial was presented at the American Heart Association’s Scientific Sessions 2024. Walid Saliba, MD speaks with Oussama Wazni, MD, Section Head of Cardiac Electrophysi...

    20 min
  8. Cardiac Imaging in the VALOR-HCM Trial

    11/21/2024

    Cardiac Imaging in the VALOR-HCM Trial

    Mavacamten is the first and only FDA-approved cardiac myosin inhibitor to treat obstructive hypertrophic cardiomyopathy (HCM). An important factor to the success of the VALOR HCM trial was the participation of specialized cardiac sonographers and imagers. Milind Desai, MD, MBA speaks with Jeanne Drinko, Amy Kanta and Anne Campbell about the importance of cardiac imaging.Learn more about C5 Research at Cleveland Clinic.https://my.clevelandclinic.org/research/c5researchLooking to refer a ...

    31 min
See All (292)

Ratings & Reviews

4.3
out of 5
38 Ratings

About

A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.

Information

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada